Eletriptan

Chemical formula: C₂₂H₂₆N₂O₂S  Molecular mass: 382.519 g/mol  PubChem compound: 77993

Therapeutic indications

Eletriptan is indicated for:

Headache phase of migraine attacks with or without aura

Population group: only adults (18 - 65 years old)

Eletriptan is indicated in adults for the acute treatment of the headache phase of migraine attacks, with or without aura.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Eletriptan is contraindicated in the following cases:

Severe hepatic impairment

Hepatic failure stage IV

Severe renal impairment

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Untreated moderately severe hypertension, untreated severe hypertension, untreated mild hypertension

Hypertension

Coronary heart disease, ischaemic heart disease, Prinzmetal angina

at least one of
Coronary arteriosclerosis
Prinzmetal angina
Ischemic heart disease

Significant arrhythmias, heart failure

at least one of
Arrhythmia
Heart failure

Peripheral vascular disease

Peripheral vascular disease

History of cerebrovascular accident (CVA), history of transient ischaemic attack (TIA)

at least one of
H/O: CVA
History of transient ischemic attack
CVA - Cerebrovascular accident
Temporary cerebral vascular dysfunction

5-HT1 receptor agonists

Selective serotonin (5HT1) agonists

Ergotamine, ergotamine derivatives

Ergot alkaloids

Hemiplegic migraine, ophthalmoplegic migraine, basilar migraine

at least one of
Hemiplegic migraine
Ophthalmoplegic migraine
Basilar migraine

Atypical headaches

Atypical cluster headache

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: RELPAX Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈